Ross DS, Burch HB, Cooper DS, Greenlee MC, Laurberg P, Maia AL, et al. 2016 American Thyroid Association Guidelines for Diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis. Thyroid. 2016;26:1343–421.
Zimmermann MB, Boelaert K. Iodine deficiency and thyroid disorders. Lancet Diabetes Endocrinol. 2015;3:286–95.
Article CAS PubMed Google Scholar
Burch HB, Wartofsky L. Life-threatening thyrotoxicosis. Thyroid storm. Endocrinol Metab Clin North Am. 1993;22:263–77.
Article CAS PubMed Google Scholar
Hall P, Lundell G, Holm LE. Mortality in patients treated for hyperthyroidism with iodine-131. Acta Endocrinol (Copenh). 1993;128:230–4.
Klein I, Becker DV, Levey GS. Treatment of hyperthyroid disease. Ann Intern Med. 1994;121:281–8.
Article CAS PubMed Google Scholar
Smith TJ, Hegedus L. Graves’ Disease. N Engl J Med. 2016;375:1552–65.
Antonelli A, Fallahi P, Elia G, Ragusa F, Paparo SR, Ruffilli I, et al. Graves’ disease: clinical manifestations, immune pathogenesis (cytokines and chemokines) and therapy. Best Pract Res Clin Endocrinol Metab. 2020;34:101388.
Article CAS PubMed Google Scholar
Norman AW. From vitamin D to hormone D: fundamentals of the vitamin D endocrine system essential for good health. Am J Clin Nutr. 2008;88:S491–9.
Deluca HF. History of the discovery of vitamin D and its active metabolites. Bonekey Rep. 2014;3:479.
Article PubMed PubMed Central Google Scholar
Gallo D, Piantanida E, Badino P, Mortara L. The story of a vitamin for bone health that upgraded to hormone for systemic good health.
Gallo D, Mortara L, Gariboldi MB, Cattaneo S, a. M, Rosetti S, Gentile L, et al. Immunomodulatory effect of vitamin D and its potential role in the prevention and treatment of thyroid autoimmunity: a narrative review. J Endocrinol Invest. 2020;43:413–29.
Article CAS PubMed Google Scholar
Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RL. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. 1986. J Immunol. 2005;175:5–14.
Kim D. The role of vitamin D in thyroid diseases. Int J Mol Sci. 2017;18:1949.
Article PubMed PubMed Central Google Scholar
Rapoport B, McLachlan SM. Graves’ hyperthyroidism is antibody-mediated but is predominantly a Th1-Type cytokine disease. J Clin Endocrinol Metabolism. 2014;99:4060–1.
Rapoport B, McLachlan SM. Reflections on thyroid autoimmunity: a personal overview from the past into the future. Horm Metab Res. 2018;50:840–52.
Article CAS PubMed Google Scholar
Plazinska MT, Czarnywojtek A, Sawicka-Gutaj N, Zgorzalewicz-Stachowiak M, Czarnocka B, Gut P, et al. Vitamin D deficiency and thyroid autoantibody fluctuations in patients with Graves’ disease - A mere coincidence or a real relationship? Adv Med Sci. 2020;65:39–45.
Article CAS PubMed Google Scholar
Muscogiuri G, Tirabassi G, Bizzaro G, Orio F, Paschou SA, Vryonidou A, et al. Vitamin D and thyroid disease: to D or not to D? Eur J Clin Nutr. 2015;69:291–6.
Article CAS PubMed Google Scholar
D’Aurizio F, Villalta D, Metus P, Doretto P, Tozzoli R. Is vitamin D a player or not in the pathophysiology of autoimmune thyroid diseases? Autoimmun Rev. 2015;14:363–9.
Effraimidis G, Badenhoop K, Tijssen JG, Wiersinga WM. Vitamin D deficiency is not associated with early stages of thyroid autoimmunity. Eur J Endocrinol. 2012;167:43–8.
Article CAS PubMed Google Scholar
Wang J, Lv S, Chen G, Gao C, He J, Zhong H, et al. Meta-analysis of the Association between Vitamin D and autoimmune thyroid disease. Nutrients. 2015;7:2485–98.
Article CAS PubMed PubMed Central Google Scholar
Xu M-Y, Cao B, Yin J, Wang D-F, Chen K-L, Lu Q-B. Vitamin D and Graves’ disease: a meta-analysis update. Nutrients. 2015;7:3813–27.
Article CAS PubMed PubMed Central Google Scholar
Fahmy O, Fahmy UA, Alhakamy NA, Khairul-Asri MG. Single-Port versus multiple-Port Robot-assisted radical prostatectomy: a systematic review and Meta-analysis. J Clin Med. 2021;10:5723.
Article PubMed PubMed Central Google Scholar
Taheriniya S, Arab A, Hadi A, Fadel A, Askari G. Vitamin D and thyroid disorders: a systematic review and Meta-analysis of observational studies. BMC Endocr Disord. 2021;21:171.
Article CAS PubMed PubMed Central Google Scholar
Feng Y, Qiu T, Chen H, Wei Y, Jiang X, Zhang H, et al. Association of serum IL-21 and vitamin D concentrations in Chinese children with autoimmune thyroid disease. Clin Chim Acta. 2020;507:194–8.
Article CAS PubMed Google Scholar
Heisel CJ, Riddering AL, Andrews CA, Kahana A. Serum vitamin D Deficiency is an independent risk factor for thyroid Eye Disease. Ophthalmic Plast Reconstr Surg. 2020;36:17–20.
Mangaraj S, Choudhury A, Swain B, Sarangi P, Mohanty B, Baliarsinha A. Evaluation of vitamin D status and its impact on thyroid related parameters in new onset Graves’ disease- A cross-sectional observational study. Indian J Endocr Metab. 2019;23:35.
Planck T, Shahida B, Malm J, Manjer J. Vitamin D in Graves Disease: levels, correlation with Laboratory and Clinical parameters, and Genetics. Eur Thyroid J. 2018;7:27–33.
Article CAS PubMed Google Scholar
Ke W, Sun T, Zhang Y, He L, Wu Q, Liu J, et al. 25-Hydroxyvitamin D serum level in Hashimoto’s thyroiditis, but not Graves’ disease is relatively deficient. Endocr J. 2017;64:581–7
Li X, Wang G, Lu Z, Chen M, Tan J, Fang X. Serum 25-hydroxyvitamin D predict prognosis in radioiodine therapy of Graves’ disease. J Endocrinol Invest. 2015;38:753–9.
Article CAS PubMed Google Scholar
Ma J, Wu D, Li C, Fan C, Chao N, Liu J, et al. Lower serum 25-Hydroxyvitamin D level is Associated with 3 types of autoimmune thyroid diseases. Medicine. 2015;94:e1639.
Article CAS PubMed PubMed Central Google Scholar
Zhang H, Liang L, Xie Z. Low vitamin D status is Associated with increased thyrotropin-receptor antibody titer in Graves Disease. Endocr Pract. 2015;21:258–63.
Yasuda T, Okamoto Y, Hamada N, Miyashita K, Takahara M, Sakamoto F, et al. Serum vitamin D levels are decreased in patients without remission of Graves’ disease. Endocrine. 2013;43:230–2.
Article CAS PubMed Google Scholar
Jyotsna VP, Sahoo A, Ksh SA, Sreenivas V, Gupta N. Bone mineral density in patients of Graves disease pre- & post-treatment in a predominantly vitamin D deficient population. Indian J Med Res. 2012;135:36–41.
Article CAS PubMed PubMed Central Google Scholar
Czernobilsky H, Scharla S, Schmidt-Gayk H, Ziegler R. Enhanced suppression of 1,25(OH)2D3 and intact parathyroid hormone in Graves’ disease as compared to toxic nodular goiter. Calcif Tissue Int. 1988;42:5–12.
留言 (0)